Stockreport

Aimmune shares surge 10% on positive late-stage trial results for peanut allergy drug [MarketWatch]

AIMMUNE THERAPEUTICS  (AIMT) 
Last aimmune therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aimmune.com/corporate-profile
PDF Aimmune shares surge 10% on positive late-stage trial results for peanut allergy drug Aimmune Therapeutics Inc. AIMT, +6.42% shares rose 9.8% in premarket trade Tuesd [Read more]